Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68beb194933ec7924333073c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PYRITIGMIN RIVA 1.5",
"description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.",
"price": 192.0,
"discountamount": 58.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2176,
"imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-08T10:36:04.37Z",
"updatedon": "2025-09-08T10:36:04.37Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "rivastigmine 1.5 mg capsule",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c15c3d89239081848a6ac",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ZIPRANODE 40 ",
"description": "ZIPRANODE 40 \nZiprasidone Capsules (40mg)\nIntroduction:\n\nZIPRANODE 40 contains Ziprasidone, an atypical antipsychotic medication, at a dosage strength of 40mg. It is designed for the treatment of schizophrenia and the manic or mixed episodes associated with bipolar disorder. ZIPRANODE 40 works by modulating the activity of neurotransmitters in the brain, helping to stabilize mood and reduce psychotic symptoms.\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nZIPRANODE 40 is effective in treating the symptoms of schizophrenia, including hallucinations, delusions, thought disorders, and social withdrawal. It helps restore balance to neurotransmitters in the brain, particularly dopamine and serotonin.\nMood Stabilization:\n\nZiprasidone is also used to manage manic or mixed episodes in bipolar disorder. It helps control mood swings, reducing the intensity and frequency of manic episodes and helping patients maintain a stable mood.\nDual Mechanism of Action:\n\nZIPRANODE 40 acts as both a serotonin and dopamine receptor antagonist. This dual mechanism of action helps in effectively managing a broad range of symptoms associated with schizophrenia and bipolar disorder.\nFavorable Side Effect Profile:\n\nCompared to other antipsychotics, Ziprasidone has a lower risk of causing weight gain and metabolic disturbances, making it a preferred option for long-term management of psychiatric conditions.\nDosage and Administration:\n\nInitial Dosage for Schizophrenia:\n\nThe recommended starting dose of ZIPRANODE 40 for adults with schizophrenia is 20mg twice daily. The dose can be increased gradually based on the patient’s response and tolerability, up to a maximum of 80mg twice daily.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of manic or mixed episodes in bipolar disorder, the initial dose is 40mg twice daily. The dose can be adjusted based on clinical response, with a usual range of 40-80mg twice daily.\nAdministration Instructions:\n\nZIPRANODE 40 capsules should be taken orally with food to enhance absorption. Swallow the capsules whole with water. Do not crush or chew the capsules.\nContinued Monitoring:\n\nRegular monitoring of symptoms, side effects, and overall health is essential during ZIPRANODE 40 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/zipranode-40-133982",
"price": 185.0,
"discountamount": 55.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"80mg",
"40mg",
"food",
"EMAIL",
"water",
"brain",
"adults",
"balance",
"maximum",
"activity",
"patients",
"Benefits",
"serotonin",
"intensity",
"delusions",
"treatment",
"frequency",
"absorption",
"lower risk",
"stable mood",
"usual range",
"broad range",
"information",
"weight gain",
"mood swings",
"initial dose",
"sterisonline",
"tolerability",
"Key Features",
"side effects",
"sterispharma",
"Introduction",
"starting dose",
"schizophrenia",
"CALL/WHATSAPP",
"hallucinations",
"patient safety",
"manic episodes",
"overall health",
"mixed episodes",
"Dual Mechanism",
"Initial Dosage",
"dosage strength",
"bipolar disorder",
"thought disorders",
"social withdrawal",
"clinical response",
"ZIPRANODE 40 acts",
"neurotransmitters",
"Mood Stabilization",
"psychotic symptoms",
"Regular monitoring",
"Antipsychotic Action",
"therapeutic efficacy",
"ZIPRANODE 40 therapy",
"Continued Monitoring",
"long-term management",
"Ziprasidone Capsules",
"other antipsychotics",
"ZIPRANODE 40 capsules",
"psychiatric conditions",
"metabolic disturbances",
"Administration Instructions",
"dopamine receptor antagonist",
"Favorable Side Effect Profile",
"atypical antipsychotic medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1913,
"imageuri": "https://productimages.withfloats.com/actual/667d1364c134db5b38ba45ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d1364c134db5b38ba45ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T10:04:51.679Z",
"updatedon": "2024-06-29T12:17:40.602Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/zipranode-40-/1913",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ZIPRANODE 40 ",
"category": "NEUROLOGY RANGE",
"tags": [
"Ziprasidone Capsules (40mg)",
"ZIPRANODE 40",
"",
"ziprasidone side effects",
"ziprasidone warnings",
"ziprasidone side effects weight loss",
"ziprasidone mechanism of action"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c10e66641561b0446977f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VELAXFINE XR 37.5 ",
"description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393",
"price": 58.0,
"discountamount": 17.4,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"MDD",
"SAD",
"day",
"GAD",
"food",
"life",
"SNRI",
"mood",
"75mg",
"need",
"EMAIL",
"water",
"brain",
"lives",
"225mg",
"37.5mg",
"levels",
"adults",
"option",
"control",
"ability",
"evening",
"morning",
"response",
"patients",
"Benefits",
"sweating",
"24 hours",
"adherence",
"intervals",
"increments",
"medication",
"depression",
"Venlafaxine",
"information",
"restlessness",
"palpitations",
"sterispharma",
"sterisonline",
"Introduction",
"Key Features",
"CALL/WHATSAPP",
"starting dose",
"panic disorder",
"Initial Dosage",
"patient safety",
"steady release",
"Anxiety Relief",
"excessive worry",
"dosage strength",
"Improved Quality",
"physical symptoms",
"treatment regimen",
"Regular monitoring",
"Dosage adjustments",
"Maintenance Dosage",
"therapeutic efficacy",
"Continued Monitoring",
"multiple daily doses",
"long-term management",
"Antidepressant Action",
"overall effectiveness",
"usual maintenance dose",
"potential side effects",
"social anxiety disorder",
"favorable safety profile",
"VELAXFINE XR 37.5 therapy",
"various anxiety disorders",
"consistent symptom relief",
"major depressive disorder",
"VELAXFINE XR 37.5 capsules",
"gastrointestinal discomfort",
"Administration Instructions",
"Extended-Release Formulation",
"generalized anxiety disorder",
"sustained therapeutic effects",
"serotonin-norepinephrine reuptake inhibitor"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1910,
"imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:44:06.065Z",
"updatedon": "2024-06-27T07:29:09.447Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VELAXFINE XR 37.5 ",
"category": "NEUROLOGY RANGE",
"tags": [
"venlafaxine 37.5 mg",
"VELAXFINE XR 37.5",
"",
"VELAXFINE XR 37.5 side effects",
"venlafaxine 37.5mg used for",
"venlafaxine urinary side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c1007162db0236048bac5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VALPOTREAT CR 500 ",
"description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217",
"price": 121.18,
"discountamount": 36.35,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"day",
"life",
"food",
"time",
"need",
"EMAIL",
"water",
"brain",
"adults",
"option",
"product",
"quality",
"epilepsy",
"severity",
"patients",
"Benefits",
"frequency",
"two doses",
"adherence",
"medication",
"mood swings",
"information",
"initial dose",
"GABA) levels",
"tolerability",
"sterispharma",
"Key Features",
"Introduction",
"sterisonline",
"various types",
"CALL/WHATSAPP",
"liver function",
"Initial Dosage",
"patient safety",
"overall health",
"manic episodes",
"steady release",
"mood stability",
"mood stabilizer",
"symptom control",
"frequent dosing",
"dosage strength",
"seizure episodes",
"absence seizures",
"bipolar disorder",
"treatment regimen",
"clinical response",
"neuronal activity",
"Mood Stabilization",
"Regular monitoring",
"Sodium Valproate CR",
"Continued Monitoring",
"long-term management",
"therapeutic efficacy",
"Anticonvulsant Action",
"potent anticonvulsant",
"usual maintenance dose",
"gamma-aminobutyric acid",
"consistent blood levels",
"favorable safety profile",
"complex partial seizures",
"typical maintenance dose",
"VALPOTREAT CR 500 therapy",
"VALPOTREAT CR 500 tablets",
"gastrointestinal discomfort",
"Administration Instructions",
"sustained therapeutic effects",
"Controlled-Release Formulation",
"generalized tonic-clonic seizures",
"controlled-release (CR) formulation"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1909,
"imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:40:23.921Z",
"updatedon": "2024-06-26T05:53:21.154Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VALPOTREAT CR 500 ",
"category": "NEUROLOGY RANGE",
"tags": [
"Sodium Valproate CR 500 mg",
"VALPOTREAT CR 500",
"",
"VALPOTREAT CR 500 price",
"",
"valprol cr 500 uses and side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c0efb162db0236048ba8c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VALPOTREAT CR 300 ",
"description": "VALPOTREAT CR 300 \nSodium Valproate CR 300 mg\nIntroduction:\n\nVALPOTREAT CR 300 contains Sodium Valproate, a highly effective anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 300mg, VALPOTREAT CR 300 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 300 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 300 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 300 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 300 for adults typically starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 300 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-300-134219",
"price": 78.0,
"discountamount": 23.4,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"day",
"life",
"time",
"food",
"need",
"EMAIL",
"brain",
"water",
"adults",
"option",
"quality",
"patients",
"Benefits",
"severity",
"epilepsy",
"adherence",
"two doses",
"frequency",
"medication",
"information",
"mood swings",
"Introduction",
"initial dose",
"sterisonline",
"sterispharma",
"tolerability",
"GABA) levels",
"Key Features",
"various types",
"CALL/WHATSAPP",
"overall health",
"Initial Dosage",
"patient safety",
"mood stability",
"manic episodes",
"steady release",
"liver function",
"mood stabilizer",
"dosage strength",
"symptom control",
"frequent dosing",
"bipolar disorder",
"absence seizures",
"seizure episodes",
"neuronal activity",
"treatment regimen",
"clinical response",
"Regular monitoring",
"Mood Stabilization",
"Sodium Valproate CR",
"long-term management",
"therapeutic efficacy",
"Continued Monitoring",
"Anticonvulsant Action",
"usual maintenance dose",
"gamma-aminobutyric acid",
"consistent blood levels",
"effective anticonvulsant",
"complex partial seizures",
"typical maintenance dose",
"favorable safety profile",
"VALPOTREAT CR 300 therapy",
"VALPOTREAT CR 300 tablets",
"Administration Instructions",
"gastrointestinal discomfort",
"sustained therapeutic effects",
"Controlled-Release Formulation",
"generalized tonic-clonic seizures"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1908,
"imageuri": "https://productimages.withfloats.com/actual/666c0efef068be46bdec91c1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c0efef068be46bdec91c1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:35:55.629Z",
"updatedon": "2024-06-29T12:22:31.565Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-300-/1908",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VALPOTREAT CR 300 ",
"category": "NEUROLOGY RANGE",
"tags": [
"Sodium Valproate CR 300 mg",
"VALPOTREAT CR 300",
"",
"VALPOTREAT CR 300",
"valprol cr 300 side effects",
"valprol cr 300 generic name",
"valprol cr 300 dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c0dc4a20cb421407442bd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VALPOTREAT CR 200 ",
"description": "VALPOTREAT CR 200 \nSodium Valproate CR 200 mg\nIntroduction:\n\nVALPOTREAT CR 200 contains Sodium Valproate, a widely used anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 200mg, VALPOTREAT CR 200 is designed to provide sustained therapeutic effects for the management of epilepsy and bipolar disorder, improving the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 200 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer in the treatment of bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 200 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This helps in achieving better symptom control and improving adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 200 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 200 for adults typically starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 200 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 200 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-200-134218",
"price": 75.0,
"discountamount": 22.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"day",
"need",
"life",
"GABA",
"food",
"time",
"EMAIL",
"water",
"brain",
"adults",
"option",
"product",
"quality",
"severity",
"epilepsy",
"Benefits",
"patients",
"adherence",
"frequency",
"two doses",
"medication",
"information",
"mood swings",
"Introduction",
"initial dose",
"Key Features",
"tolerability",
"sterispharma",
"sterisonline",
"CALL/WHATSAPP",
"various types",
"patient safety",
"Initial Dosage",
"overall health",
"steady release",
"liver function",
"mood stability",
"manic episodes",
"dosage strength",
"mood stabilizer",
"symptom control",
"frequent dosing",
"absence seizures",
"bipolar disorder",
"seizure episodes",
"clinical response",
"treatment regimen",
"neuronal activity",
"Regular monitoring",
"Mood Stabilization",
"Sodium Valproate CR",
"therapeutic efficacy",
"long-term management",
"Continued Monitoring",
"Anticonvulsant Action",
"usual maintenance dose",
"consistent blood levels",
"gamma-aminobutyric acid",
"typical maintenance dose",
"complex partial seizures",
"favorable safety profile",
"VALPOTREAT CR 200 therapy",
"VALPOTREAT CR 200 tablets",
"gastrointestinal discomfort",
"Administration Instructions",
"sustained therapeutic effects",
"Controlled-Release Formulation",
"generalized tonic-clonic seizures",
"controlled-release (CR) formulation"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1907,
"imageuri": "https://productimages.withfloats.com/actual/666c0dc8c9162f54a15a020e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c0dc8c9162f54a15a020e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:30:44.587Z",
"updatedon": "2024-06-26T09:16:37.475Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-200-/1907",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VALPOTREAT CR 200 ",
"category": "NEUROLOGY RANGE",
"tags": [
"VALPOTREAT CR 200",
"Sodium Valproate CR 200 mg",
"valpotreat cr 200 uses in hindi",
"valprol cr 200 uses in hindi",
"valpotreat cr 200 expiry date",
"valpotreat"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c0208d89239081848a527",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "STARGAB 300 ",
"description": "STARGAB 300 \nGabapentin 300 mg\nIntroduction:\n\nSTARGAB 300 contains Gabapentin, a versatile anticonvulsant and neuropathic pain agent widely used to manage conditions such as epilepsy and neuropathic pain. With a dosage strength of 300mg, STARGAB 300 aims to alleviate symptoms by modulating neurotransmitter release, thereby improving quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nSTARGAB 300 works by stabilizing electrical activity in the brain, making it an effective treatment for various types of seizures in patients with epilepsy. It helps reduce the frequency and severity of seizures, enhancing overall neurological stability.\nNeuropathic Pain Relief:\n\nGabapentin is particularly effective in managing neuropathic pain, which is pain caused by nerve damage. It helps reduce pain sensations, providing relief for conditions such as diabetic neuropathy, postherpetic neuralgia, and spinal cord injury-related pain.\nImproved Sleep Quality:\n\nPatients suffering from chronic pain often experience disrupted sleep. STARGAB 300 can improve sleep quality by alleviating pain, leading to better rest and overall well-being.\nMood Stabilization:\n\nIn addition to its primary uses, Gabapentin has been shown to have mood-stabilizing properties, making it beneficial for patients with mood disorders coexisting with neuropathic pain or epilepsy.\nWell-Tolerated and Safe:\n\nGabapentin is generally well-tolerated, with a favorable safety profile, making STARGAB 300 a reliable option for long-term management of neuropathic pain and seizures.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe recommended starting dose of STARGAB 300 for epilepsy is 300mg once daily on the first day, 300mg twice daily on the second day, and 300mg three times daily on the third day. The dose can be gradually increased based on clinical response and tolerability, with a maintenance dose typically ranging from 900mg to 1800mg per day, divided into three doses.\nInitial Dosage for Neuropathic Pain:\n\nFor neuropathic pain, the initial dose is typically 300mg taken once daily, gradually increasing to 300mg three times daily, based on patient response and tolerability. The maintenance dose may range from 900mg to 3600mg per day, divided into multiple doses.\nAdministration Instructions:\n\nSTARGAB 300 tablets should be taken orally with or without food. It is advisable to take the medication at the same time each day to maintain consistent therapeutic levels in the bloodstream.\nContinued Monitoring:\n\nRegular monitoring of symptoms, pain levels, and potential side effects is essential during STARGAB 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/stargab-300-134312",
"price": 155.0,
"discountamount": 46.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"rest",
"life",
"food",
"brain",
"EMAIL",
"option",
"epilepsy",
"seizures",
"addition",
"symptoms",
"severity",
"Benefits",
"patients",
"same time",
"first day",
"third day",
"frequency",
"second day",
"conditions",
"Gabapentin",
"medication",
"information",
"bloodstream",
"pain levels",
"three doses",
"nerve damage",
"Introduction",
"sterispharma",
"initial dose",
"tolerability",
"primary uses",
"chronic pain",
"Key Features",
"sterisonline",
"various types",
"CALL/WHATSAPP",
"starting dose",
"multiple doses",
"mood disorders",
"patient safety",
"Initial Dosage",
"dosage strength",
"pain sensations",
"patient response",
"maintenance dose",
"clinical response",
"Regular monitoring",
"overall well-being",
"Mood Stabilization",
"STARGAB 300 tablets",
"STARGAB 300 therapy",
"electrical activity",
"diabetic neuropathy",
"effective treatment",
"long-term management",
"Continued Monitoring",
"therapeutic efficacy",
"Anticonvulsant Action",
"neuropathic pain agent",
"potential side effects",
"postherpetic neuralgia",
"Improved Sleep Quality",
"Neuropathic Pain Relief",
"favorable safety profile",
"neurotransmitter release",
"versatile anticonvulsant",
"mood-stabilizing properties",
"Administration Instructions",
"consistent therapeutic levels",
"overall neurological stability",
"spinal cord injury-related pain"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1899,
"imageuri": "https://productimages.withfloats.com/actual/666c020b8c6c791fd3b7131b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c020b8c6c791fd3b7131b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T08:40:40.129Z",
"updatedon": "2024-06-29T12:26:43.183Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/stargab-300-/1899",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STARGAB 300 ",
"category": "NEUROLOGY RANGE",
"tags": [
"stargab 300 uses in hindi",
"stargab 300 price in hindi",
"gabapentin 300mg used for",
"gabapentin 300mg dosage",
"maximum dosage of gabapentin for nerve pain"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666bff0d4cb45413344ec745",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "STERIS GABAPENTIN 100 ",
"description": "STERIS GABAPENTIN 100 \nGabapentine (100mg)\nIntroduction:\n\nSTERIS GABAPENTIN 100 contains Gabapentin, an anticonvulsant and neuropathic pain agent widely used to manage conditions such as epilepsy and neuropathic pain. With a dosage strength of 100mg, STERIS GABAPENTIN 100 aims to alleviate symptoms by modulating neurotransmitter release, thereby improving quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nSTERIS GABAPENTIN 100 works by stabilizing electrical activity in the brain, making it an effective treatment for various types of seizures in patients with epilepsy.\nNeuropathic Pain Relief:\n\nGabapentin is particularly effective in managing neuropathic pain, which is pain caused by nerve damage. It helps reduce pain sensations, providing relief for conditions such as diabetic neuropathy, postherpetic neuralgia, and spinal cord injury-related pain.\nImproved Sleep Quality:\n\nPatients suffering from chronic pain often experience disrupted sleep. STERIS GABAPENTIN 100 can improve sleep quality by alleviating pain, leading to better rest and overall well-being.\nMood Stabilization:\n\nIn addition to its primary uses, Gabapentin has been shown to have mood-stabilizing properties, making it beneficial for patients with mood disorders coexisting with neuropathic pain or epilepsy.\nWell-Tolerated and Safe:\n\nGabapentin is generally well-tolerated, with a favorable safety profile, making STERIS GABAPENTIN 100 a reliable option for long-term management of neuropathic pain and seizures.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe recommended starting dose of STERIS GABAPENTIN 100 for epilepsy is 300mg on the first day, followed by 300mg twice daily on the second day, and 300mg three times daily on the third day. The dose can be gradually increased based on clinical response and tolerability.\nInitial Dosage for Neuropathic Pain:\n\nFor neuropathic pain, the initial dose is typically 100-300mg taken once daily, gradually increasing to 300mg three times daily based on patient response and tolerability.\nAdministration Instructions:\n\nSTERIS GABAPENTIN 100 tablets should be taken orally with or without food. It is advisable to take the medication at the same time each day to maintain consistent therapeutic levels in the bloodstream.\nContinued Monitoring:\n\nRegular monitoring of symptoms, pain levels, and potential side effects is essential during STERIS GABAPENTIN 100 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/steris-gabapentin-100-134347",
"price": 85.0,
"discountamount": 25.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"rest",
"life",
"food",
"brain",
"EMAIL",
"300mg",
"100mg",
"option",
"seizures",
"addition",
"symptoms",
"Benefits",
"patients",
"epilepsy",
"third day",
"same time",
"first day",
"medication",
"conditions",
"second day",
"Gabapentine",
"information",
"bloodstream",
"pain levels",
"nerve damage",
"Introduction",
"sterispharma",
"initial dose",
"tolerability",
"chronic pain",
"primary uses",
"Key Features",
"sterisonline",
"CALL/WHATSAPP",
"various types",
"starting dose",
"mood disorders",
"Initial Dosage",
"patient safety",
"pain sensations",
"dosage strength",
"patient response",
"clinical response",
"Regular monitoring",
"Mood Stabilization",
"overall well-being",
"electrical activity",
"effective treatment",
"diabetic neuropathy",
"Continued Monitoring",
"long-term management",
"therapeutic efficacy",
"Anticonvulsant Action",
"Improved Sleep Quality",
"neuropathic pain agent",
"potential side effects",
"postherpetic neuralgia",
"Neuropathic Pain Relief",
"neurotransmitter release",
"favorable safety profile",
"Administration Instructions",
"mood-stabilizing properties",
"STERIS GABAPENTIN 100 therapy",
"STERIS GABAPENTIN 100 tablets",
"consistent therapeutic levels",
"spinal cord injury-related pain"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1898,
"imageuri": "https://productimages.withfloats.com/actual/666bff128c6c791fd3b7123a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666bff128c6c791fd3b7123a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T08:27:57.94Z",
"updatedon": "2024-06-29T12:29:37.713Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/steris-gabapentin-100-/1898",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STERIS GABAPENTIN 100 ",
"category": "NEUROLOGY RANGE",
"tags": [
"normal dosage of gabapentin for nerve pain side ef",
"maximum dose of gabapentin for adults",
"gabapentin 100mg uses",
"gabapentin a high dose",
"uses of gabapentin capsules",
"gabapentin 100mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666be6b8aa93342004eef58f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ROPINPRIME 2 ",
"description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629",
"price": 135.0,
"discountamount": 40.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"RLS",
"1mg",
"8mg",
"life",
"aids",
"food",
"brain",
"Order",
"EMAIL",
"0.5mg",
"water",
"0.25mg",
"action",
"nausea",
"bedtime",
"disease",
"tremors",
"patients",
"Benefits",
"condition",
"Parkinson",
"stiffness",
"Ropinirole",
"likelihood",
"medication",
"information",
"Introduction",
"bradykinesia",
"independence",
"tolerability",
"initial dose",
"sterisonline",
"sterispharma",
"greater ease",
"Key Features",
"CALL/WHATSAPP",
"sleep quality",
"starting dose",
"motor symptoms",
"patient safety",
"multiple doses",
"Initial Dosage",
"overall comfort",
"treatment plans",
"slowed movement",
"symptom control",
"patient response",
"symptom severity",
"daily activities",
"clinical response",
"Maintenance doses",
"Regular monitoring",
"dopamine receptors",
"uncontrollable urge",
"2mg dosage strength",
"Ropinprime 2 therapy",
"healthcare providers",
"therapeutic efficacy",
"Continued Monitoring",
"dopaminergic activity",
"overall motor function",
"potential side effects",
"potent dopamine agonist",
"Improved Motor Function",
"uncomfortable sensations",
"flexible dosing regimens",
"individual patient needs",
"Administration Instructions",
"Swallow Ropinprime 2 tablets",
"Restless Legs Syndrome Relief"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1895,
"imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T06:44:08.261Z",
"updatedon": "2024-06-27T07:33:46.566Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ROPINPRIME 2 ",
"category": "NEUROLOGY RANGE",
"tags": [
"Ropinirole (2mg)",
"ROPINPRIME 2",
"ropinirole side effects",
"ropinirole side effects: weight gain",
"ropinirole side effects in elderly"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}